Neutrophil and platelets can stimulate cancer progression by producing vascular endothelial growth factor (VEGF) and interleukin-6 to enhance tumor angiogenesis and tumor cell epithelial-mesenchymal transition (38, 39). This evidence concerns the gene IL6 and cancer.